KRAS and cancer: That 1 to 2 20AARs provide maximal cancer risk was also found to be robust to the presence or absence of TP53, KRAS, PIK3CA, and SMAD4—canonical MSS drivers that are not primarily involved in WNT pathway regulation (Supplementary Table S7).